The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000570381
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
14/04/2026
Date registered
Help: Date registered
6/05/2026
Date last updated
Help: Date last updated
23/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
6/05/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
MindCare Digital: a culturally adapted, evidence-informed, web-based dementia prevention intervention for Culturally and Linguistically Diverse (CALD) communities in Australia
Scientific title
MindCare Digital: An Implementation Effectiveness Hybrid Type 1 Superiority Three-Arm Cluster Randomised Controlled Trial of a Culturally Adapted Digital Dementia Prevention Intervention in Culturally and Linguistically Diverse Communities in Australia
Additional trial identifiers [1] 316975 0
MRFF Application ID: 2032836
Universal Trial Number (UTN)
Trial acronym
MindCare-D
Related trial records

Health condition
Health condition(s) studied:
Dementia 341435 0
Condition category
Condition code
Neurological 337499 337499 0 0
Dementias

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Arm 1: MindCare-D

MindCare-D is a culturally adapted, evidence-informed, web-based dementia prevention intervention. It was developed using co-design methods, with input from individuals belonging to the 4 target Culturally and Linguistically Diverse (CALD) communities obtained during 9 in-person community workshops.

The intervention comprises 16 modules focussed on preventing dementia by addressing modifiable risk factors (i.e., hearing loss, vision loss, smoking, low levels of education, social isolation, depression, traumatic brain injury, air pollution, alcohol consumption, obesity, physical inactivity, high blood pressure, high cholesterol, diabetes, sleep disturbance, and healthy diet).

Each module will include a 5-minute video presented by a health professional or respected community leader, followed by ~5 minutes of culturally tailored written guidance outlining the risk factor and practical strategies for behaviour change. Modules will conclude with a structured goal-setting activity in which participants will select a goal from a predefined list aligned with the module topic. Links to reputable government and not-for-profit health resources will be provided to support further learning and action.

The modules will be delivered via La Trobe University's online learning management system (LMS). Participants will receive an individual username and password in order to access the LMS. The first two modules will be available immediately however subsequent modules will be released on a fortnightly basis to promote progressive engagement and minimise cognitive burden. Each module will require approximately 15 minutes to complete; however, participants will be able to engage at their own pace and revisit content without time restrictions or minimum engagement thresholds. In Arm 1, MindCare-D modules will be available from the time of their release (as per fortnightly release schedule) until the end of the 24-month study period. The modules will remain accessible to participants even after initial completion.

MindCare-D will comprise 5 versions to ensure cultural and linguistic relevance: a plain English language master version and 4 culturally tailored versions for South Asian, Middle Eastern, Sub-Saharan African, and Pacific Islander communities. While the core structure, theoretical foundations, and behavioural targets will remain consistent across versions, examples, imagery, dietary references, and contextual messaging will be tailored to reflect each community’s cultural values, lived experiences, and health beliefs. Materials will be available in simple English (Pasifika communities) and translated into Arabic and Persian (Middle Eastern communities), Hindi (South Asian communities), and Swahili (Sub-Saharan African communities).


Arm 2: MindCare-D Plus

Participants allocated to MindCare-D Plus will receive the MindCare-D modules in addition to personalised behavioural support for 12 months. This will include a semi-structured 15 - 20-minute monthly telephone coaching session delivered by a qualified health professional (dietitian, neuropsychologist, or medical practitioner). Coaching sessions will focus on reviewing participant-selected goals, identifying barriers, reinforcing motivation, and supporting problem-solving. Participants will receive coaching sessions with each health coach, but these may not always be equally distributed (e.g., 5 sessions x dietitian; 3 sessions x neuropsychologist; and 4 sessions x medical practitioner) due to staff leave, participant availability, and/or other unforeseen reasons. However, the research team will develop a health coaching schedule to allow participants opportunity to receive coaching/support from each of the different health professionals. Participants will be asked to schedule their monthly coaching sessions via Microsoft Bookings. If participants miss/cancel their scheduled coaching session, the research team will attempt to reschedule the session at an alternatively convenient time. There is possibility that participant availability may change during the study period, therefore a range (minimum of 10; maximum of 12) for the number of coaching sessions which should be completed has been pre-specified. Interpreter support will be available during the coaching sessions, if required.

Participants will also receive approximately twice weekly, one directional, SMS messages delivered in their preferred language. A text message service (TNZ) will be utilised to automatically send the SMS messages from REDCap. Messages will be tailored to individual goals and will reinforce behavioural strategies introduced within the program. For example, a motivational SMS about hearing ("Hi [Participant's Name], it’s [Sender Name] here from MindCare Digital. Staying connected with others becomes easier when hearing is clear. A simple check can help you stay involved.") may be sent after the healthy hearing module is released in the LMS.

In Arm 2, the modules will also be available from the time of their release (as per fortnightly release schedule) until the end of the 24-month study period. The modules will remain accessible to participants even after initial completion. Behavioural support through health coaching and SMS messages will be provided to participants for the first 12 months of the study period. The behavioural support will be personalised in that participants will have an opportunity to guide discussions around their selected goals during coaching sessions. The sessions are intended to be semi-structured therefore participants can also discuss particular risk factors they may be concerned about and/or any module content that they may have queries about. Additionally, the research team will select and send SMS messages which align with participants goals and/or intervention content that they have engaged with at the time.

Adherence and fidelity to the intervention will be monitored using several strategies. The LMS will automatically capture MindCare-D module adherence through website analytics (e.g., log-in frequency, time spent on modules, module access patterns, and goal selections). For MindCare-D Plus, record of SMS message delivery logs, coaching session attendance and discussions will be maintained. Furthermore, the research team will monitor fidelity of intervention delivery using a fidelity checklist and will document any modifications/adaptations made to the intervention.
Intervention code [1] 333718 0
Prevention
Description of the comparator or control
Participants allocated to the control arm will be directed to the LMS platform; however, they will not receive access to the MindCare-D modules. Instead, they will be provided with a digital PDF version of Dementia Australia’s Healthy Brain, Healthy Life booklet (available for the duration of the study period) and invited to set personal goals independently. No additional digital modules, coaching, or SMS support will be provided.

The control arm will receive access to the MindCare-D modules after the completion of the trial (i.e., after data collection is completed at 24-month follow-up). However, it will not be possible to provide access to MindCare-D Plus, due to an absence of funding required to facilitate personalised support from health coaches.
Control group
Active

Outcomes
Primary outcome [1] 345014 0
Change in participants' dementia risk scores.
Timepoint [1] 345014 0
Baseline, 6 months, 12 months, and 24 months post-randomisation.
Secondary outcome [1] 460139 0
Change in participants' knowledge, skills, and confidence for managing individual health and healthcare will be assessed as a composite secondary outcome.
Timepoint [1] 460139 0
Baseline, 6 months, 12 months, and 24 months post-randomisation.
Secondary outcome [2] 460140 0
Changes in participants' knowledge of dementia risk.
Timepoint [2] 460140 0
Baseline, 6 months, 12 months, and 24 months post-randomisation.
Secondary outcome [3] 460807 0
Participant acceptability of intervention.
Timepoint [3] 460807 0
Pre-intervention (immediately post-randomisation), 6 months and 12 months post-randomisation.
Secondary outcome [4] 460808 0
Staff acceptability of intervention.
Timepoint [4] 460808 0
Pre-intervention delivery, 6 months and 12 months after commencing intervention delivery
Secondary outcome [5] 460809 0
Participant adherence to intervention as a composite secondary outcome.
Timepoint [5] 460809 0
Continually assessed monthly during the 24-month intervention period.
Secondary outcome [6] 460810 0
Fidelity of trial delivery.
Timepoint [6] 460810 0
Continually assessed monthly during the 24-month intervention period.
Secondary outcome [7] 460812 0
Intervention feasibility by participants as a composite secondary outcome.
Timepoint [7] 460812 0
Interviews will be conducted at 12-24 months post-randomisation.
Secondary outcome [8] 460813 0
Intervention feasibility by staff delivering the intervention.
Timepoint [8] 460813 0
Interviews will be conducted at 12-24 months after commencing intervention delivery.

Eligibility
Key inclusion criteria
Individuals who identify as belonging to one of the four target CALD communities: South Asian, Middle Eastern, Sub-Saharan African, or Pacific Islander; aged 45-75 years old; and have access to the internet and are able to operate a computer, laptop, tablet, or smartphone.
Minimum age
45 Years
Maximum age
75 Years
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
Individuals who have experienced a cardiovascular event (e.g., stroke) within the past six months; have a clinical diagnosis of dementia, or referral to memory clinic for memory testing; any underlying medical condition likely to limit life expectancy to less than 12 months; and/or confirmed overseas travel for a duration of 6+ months during the first year of the trial.

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
To minimise risk for any potential selection bias during the trial recruitment period, the research team will conceal cluster allocation from our multicultural partners who will undertake participant recruitment. Clusters will not be allocated into a trial arm until recruitment for a cluster is completed. We will also request that participants do not share details of their allocation with our multicultural partners and other individuals outside of their cluster.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
To minimise contamination across trial arms, randomisation will occur at the community level, as often the target CALD communities are organised into pre-existing local social groups (e.g., walking group). Following completion of baseline measures, groups of >15 participants (cluster) will be randomised (using a computer-generated random allocation sequence) in a 1:1:1 ratio to one of the three arms. A member from the biostatistician’s team will generate the random allocation sequence.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
To detect a small-medium effect in a three-group design (1:1:1) with four repeated measures, a 5% risk of type 1 error, 80% power and moderate participant correlation (r equal to 0.5), a total sample size of 621 (207 per group) persons is required. To accommodate 20% attrition, 776 participants will be recruited. A small effect (0.25 standard deviation [SD]) on the CogDrisk is 1.1 points at mid-life and 1.5 points later-life (Anstey et al., 2026). Sample size calculations were estimated using G*Power (version 3.1.9.7).

The primary analysis will follow the intention-to-treat principle, including all randomised participants. For the three-group (1:1:1) design with four repeated measures, mixed-effects linear regression models will be used to assess change in the primary outcome (CogDrisk score) over time. Participant will be included as a random effect to account for repeated measures. Cluster will also be specified as a random effect, or may be included as fixed effect if required. The model will be adjusted for baseline CogDrisk score, since the CogDrisk score already considers the participants age and other demographics. Additional baseline characteristics associated with the primary outcome, identified through preliminary univariate analyses or expert stakeholder input, may also be included as fixed effects. Results will be reported as standardized ß coefficients with 95% confidence intervals and corresponding p-values. Secondary outcomes will be analysed using similar modelling approaches where appropriate.

Missing data across the study period will be examined and reported. To assess the robustness of the main analysis, multiple imputation by chained equations (MICE) will be used to account for missing outcome data.

Prespecified subgroup and sensitivity analyses may include breakdowns by age, gender, ethnicity, education/occupation.

For the mixed-methods implementability evaluation, qualitative feasibility (interview) data will be analysed thematically using NVivo 15. Quantitative fidelity and acceptability data will be analysed to determine intervention adherence and acceptability rates.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,NT,QLD,SA,TAS,WA,VIC

Funding & Sponsors
Funding source category [1] 321573 0
Government body
Name [1] 321573 0
Department of Health and Aged Care, Medical Research Future Fund (MRFF) Dementia Ageing and Aged Care Mission
Country [1] 321573 0
Australia
Primary sponsor type
University
Name
La Trobe University
Address
Country
Australia
Secondary sponsor category [1] 324372 0
None
Name [1] 324372 0
Address [1] 324372 0
Country [1] 324372 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320104 0
La Trobe University Human Research Ethics Committee
Ethics committee address [1] 320104 0
Ethics committee country [1] 320104 0
Australia
Date submitted for ethics approval [1] 320104 0
01/04/2026
Approval date [1] 320104 0
11/05/2026
Ethics approval number [1] 320104 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149442 0
Prof Bianca Brijnath
Address 149442 0
La Trobe University, School of Humanities and Social Sciences, Plenty Rd, Bundoora, VIC 3086
Country 149442 0
Australia
Phone 149442 0
+61 433 043 708
Fax 149442 0
Email 149442 0
Contact person for public queries
Name 149443 0
Nazgol Karimi
Address 149443 0
La Trobe University, School of Humanities and Social Sciences, Plenty Rd, Bundoora, VIC 3086
Country 149443 0
Australia
Phone 149443 0
+61 410825300
Fax 149443 0
Email 149443 0
Contact person for scientific queries
Name 149444 0
Nazgol Karimi
Address 149444 0
La Trobe University, School of Humanities and Social Sciences, Plenty Rd, Bundoora, VIC 3086
Country 149444 0
Australia
Phone 149444 0
+61 410825300
Fax 149444 0
Email 149444 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
What individual participant data might be shared?
• De-identified individual participant data:
• Published results
What types of analyses could be done with individual participant data?
• Studies testing whether findings can be repeated or confirmed
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
Not yet decided
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: Data requests should be sent to the Coordinating Principal Investigator at [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.